Brief: Theranexus End-Q3 Available Funds Down At EUR 11.0 Mln

Thx Pharma SA

19/10/2022 17:20

Oct 19 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * AT END OF Q3, TOTAL AVAILABLE FUNDS STOOD AT EUR11.0
MILLION
COMPARED TO EUR11.6 MILLION ON JUNE 30, 2022
    * CASH CONSUMPTION WAS IN LINE WITH COMPANY'S FORECASTS FOR
PERIOD
AND PROVIDES THERANEXUS WITH FINANCIAL VISIBILITY FOR REMAINDER
OF 2022 AND 2023
    * HAS COMFORTABLE FINANCIAL LEEWAY TO PURSUE ITS PHASE I/II
CLINICAL TRIAL OF DRUG CANDIDATE BATTEN-1 FOR WHICH LAST PATIENT
WAS ENROLLED DURING THIS QUARTER

Source text for Eikon:  ID:nACT76796 
Further company coverage:  ALTHX.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))